Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lacosamide in Pediatric Focal Refractory Epilepsy
NCT04144218Phase 4Unknown
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Nov 2019
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lacosamide in focal epilepsy (2 arms), sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Primary endpoints: Frequency of weekly seizures at 16 weeks, Serum alanine aminotransferase at 1 year and 2 more. Status: unknown.
02
Drugs
lacosamide
03
Conditions
focal epilepsy
Beyond the preview
Go deeper on NCT04144218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04144218.